Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Health Catalyst (HCAT) Receivables - Other (2018 - 2026)

Health Catalyst filings provide 9 years of Receivables - Other readings, the most recent being $6.5 million for Q1 2026.

  • On a quarterly basis, Receivables - Other fell 15.58% to $6.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.5 million, a 15.58% decrease, with the full-year FY2025 number at $10.1 million, down 14.41% from a year prior.
  • Receivables - Other hit $6.5 million in Q1 2026 for Health Catalyst, down from $10.1 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $11.8 million in Q4 2024 to a low of $500000.0 in Q2 2022.
  • Median Receivables - Other over the past 5 years was $4.7 million (2023), compared with a mean of $5.0 million.
  • Biggest five-year swings in Receivables - Other: tumbled 58.33% in 2022 and later soared 422.22% in 2023.
  • Health Catalyst's Receivables - Other stood at $900000.0 in 2022, then soared by 422.22% to $4.7 million in 2023, then skyrocketed by 151.06% to $11.8 million in 2024, then dropped by 14.41% to $10.1 million in 2025, then plummeted by 35.64% to $6.5 million in 2026.
  • The last three reported values for Receivables - Other were $6.5 million (Q1 2026), $10.1 million (Q4 2025), and $8.5 million (Q3 2025) per Business Quant data.